BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25296233)

  • 1. The increasing clinical importance of alloantibodies in kidney transplantation.
    Pankewycz O; Soliman K; Laftavi MR
    Immunol Invest; 2014; 43(8):775-89. PubMed ID: 25296233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Alloantibodies in Solid Organ Transplantation.
    Everly MJ
    Clin Transpl; 2014; ():125-9. PubMed ID: 26281136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in understanding humoral rejection in kidney transplantation: implications for patient management.
    Pascual MA; Crespo M; Tolkoff-Rubin N
    Nefrologia; 2001; 21(4):327-31. PubMed ID: 11816504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies.
    Opelz G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1570-6. PubMed ID: 15866311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes.
    Banasik M; Boratyńska M; Kościelska-Kasprzak K; Krajewska M; Mazanowska O; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Nowakowska B; Hałoń A; Dawiskiba T; Chudoba P; Klinger M
    Transpl Immunol; 2014 Jan; 30(1):24-9. PubMed ID: 24184747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of antibodies in kidney transplant].
    Ruffoni E; Seveso M; Marson P; Tison T; Cozzi E
    G Ital Nefrol; 2012; 29 Suppl 54():S54-60. PubMed ID: 22388831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of specific anty-HLA alloantibodies before and after renal transplantation. Programs for highly sensitized recipients].
    Zielińska H; Zieliński M; Moszkowska G; Debska-Slizień A; Jankowska MM; Rutkowski B; Trzonkowski P
    Postepy Hig Med Dosw (Online); 2009 Sep; 63():435-48. PubMed ID: 19837986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of pre- and post-transplant HLA antibodies, donor-specific, and nondonor-specific HLA antibodies detected by ELISA in renal transplantation.
    Lee PC; Chen YL; Wang WM; Tu WC; Chen HY
    Clin Transpl; 2013; ():385-91. PubMed ID: 25095533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of antibody-mediated kidney transplant rejection.
    Morath C; Opelz G; Zeier M; Süsal C
    Transpl Int; 2012 Jun; 25(6):633-45. PubMed ID: 22587522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-human leukocyte antigen DQ antibodies in renal transplantation: Are we underestimating the most frequent donor specific alloantibodies?
    Carta P; Di Maria L; Caroti L; Buti E; Antognoli G; Minetti EE
    Transplant Rev (Orlando); 2015 Jul; 29(3):135-8. PubMed ID: 25976621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing relevance of donor-specific antibodies in antibody-mediated rejection.
    Zito A; Schena A; Grandaliano G; Gesualdo L; Schena FP
    J Nephrol; 2013; 26(2):237-42. PubMed ID: 23475460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo production of donor-specific anti-HLA alloantibodies in early acute humoral renal allograft rejection.
    Spriewald BM; Hugo C
    Clin Transpl; 2006; ():469-72. PubMed ID: 18365405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact.
    Seveso M; Bosio E; Ancona E; Cozzi E
    Contrib Nephrol; 2009; 162():87-98. PubMed ID: 19001816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
    Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immunity and antibody-mediated rejection in solid organ transplantation.
    Montgomery RA; Cozzi E; West LJ; Warren DS
    Semin Immunol; 2011 Aug; 23(4):224-34. PubMed ID: 21958960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac antibody-mediated rejection.
    Chin C
    Pediatr Transplant; 2012 Aug; 16(5):404-12. PubMed ID: 22500558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular helper T cells and humoral response in organ transplantation.
    Laguna-Goya R; Suàrez-Fernández P; Paz-Artal E
    Transplant Rev (Orlando); 2019 Oct; 33(4):183-190. PubMed ID: 31327572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.